Skip to content

Menu

LexBlog, Inc. logo
NetworkSub-MenuBrowse by SubjectBrowse by PublisherJoin the NetworkGet StartedSubscribeSupport
Contact Us
Search
Close

World Health Organization urges moratorium for COVID-19 booster shots

By Yvonne Puig (US), Daphne Calderon (US) & Hannah Putnam (US) on August 10, 2021
Email this postTweet this postLike this postShare this post on LinkedIn

On August 4, 2021, Director-General Tedros Adhanom Ghebreyesus of the World Health Organization (“WHO”) emphasized the import of delaying the administration of booster shots for the COVID-19 vaccine until at least September 2021. He believes this delay will allow at least 10% of the population of every country to be vaccinated against COVID-19.

Director Ghebreyesus emphasized the wealth disparity in vaccine distribution and advocated for an “urgent reversal” of the current trend. The director stated that the world cannot, and should not, accept high income countries that have already used most of the global supply of vaccines to use even more of that supply to re-vaccinate their populations with booster shots. He urged this was especially true considering how few individuals from low income countries have received the first round of vaccinations.

The director noted that more than 80% of the world’s administered vaccines were distributed in high and upper-middle income countries. According to the WHO, hundreds of millions of people are still waiting for an opportunity to be vaccinated with low income countries only able to administer 1.5 doses for every 100 people due to lack of supply thus far. Conversely, high income countries are now administering almost 100 doses for every 100 people. And delaying the administration of a booster shot should enable more vulnerable populations to receive the vaccine before the higher income countries begin to re-vaccinate their populations with a booster.

Norton Rose Fulbright lawyers will continue to provide relevant updates for healthcare providers on the Health Law Pulse during the COVID-19 public health crisis.

Photo of Yvonne Puig (US) Yvonne Puig (US)

US Head of Life Sciences and Healthcare Yvonne Puig has a substantial commercial litigation practice in both state and federal courts. She represents hospitals, HMOs, managed care organizations, medical schools and other institutional health care providers and educational services companies. A partner in…

US Head of Life Sciences and Healthcare Yvonne Puig has a substantial commercial litigation practice in both state and federal courts. She represents hospitals, HMOs, managed care organizations, medical schools and other institutional health care providers and educational services companies. A partner in Norton Rose Fulbright’s Austin office, Yvonne’s practice involves commercial and health care litigation, antitrust, regulatory and compliance advice, crisis management, staff privileges, exclusive contracting and administrative law.

Read more about Yvonne Puig (US)Email
Show more Show less
Photo of Daphne Calderon (US) Daphne Calderon (US)
Read more about Daphne Calderon (US)Email
Photo of Hannah Putnam (US) Hannah Putnam (US)
Read more about Hannah Putnam (US)Email
  • Posted in:
    Health Care and Life Sciences
  • Blog:
    Health Law Pulse
  • Organization:
    Norton Rose Fulbright
  • Article: View Original Source

Call us at 1-800-913-0988 or email sales@lexblog.com.

Facebook LinkedIn Twitter RSS
  • About LexBlog
  • The Field We Built
  • Our Beliefs
  • Our Team
  • Contact LexBlog
  • Disclaimer
  • Editorial Policy
  • Terms of Service
  • Get Started
  • Publishing Solutions
  • Compass
  • Submit a Request
  • Support Center
  • System Status
Copyright © 2026, LexBlog, Inc. All Rights Reserved.
Law blog design & platform by LexBlog LexBlog Logo